Notice of Effectiveness (effect)
31 Marzo 2023 - 4:20AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | March 30,
2023 |
---|
Form: | F-1 |
---|
CIK: | 0001885827 |
---|
Company Name: | Virax Biolabs Group Ltd |
---|
File Number: | 333-270734 |
---|
Virax Biolabs (NASDAQ:VRAX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Virax Biolabs (NASDAQ:VRAX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024